Skip Nav Destination
Drug Discovery Series
The Drug Discovery Series covers all aspects of drug discovery and medicinal chemistry and contains over seventy books published since 2010. Providing comprehensive coverage of this important and far-reaching area, the books encourage learning in a range of different topics and provide valuable reference sources for scientists working outside their own areas of expertise. Books feature case studies to bring different aspects of the drug discovery process alive and they detail the fundamental science necessary for understanding through to the most up-to-date discoveries and cutting-edge technologies. Chapters are written and edited by experienced researchers from both industry and academia. This series will be of particular interest to postgraduate students and medicinal chemists and biochemists working in academia or industry.
Series DOI: 10.1039/2041-3211; Print ISSN: 2041-3203; Electronic ISSN: 2041-3211
Editor-in-Chief
Simon Ward; Cardiff University, UK
Series Editors
David Fox; Vulpine Science & Learning, UK
Ian Storer; AstraZeneca, UK
Gina Xiaojing Wang; Genentech, Inc. USA
Series DOI: 10.1039/2041-3211; Print ISSN: 2041-3203; Electronic ISSN: 2041-3211
Editor-in-Chief
Simon Ward; Cardiff University, UK
Series Editors
David Fox; Vulpine Science & Learning, UK
Ian Storer; AstraZeneca, UK
Gina Xiaojing Wang; Genentech, Inc. USA

High Content Imaging in Drug Discovery
Check Access
James Pilling; Neil Carragher
DNA-encoded Library Technology for Drug Discovery
Check Access
Guansai Liu; Casey J Krusemark; Jin Li
Tatiana V Lipina
Epigenetic Drug Discovery
Check Access
Ho Man Chan; Cheryl Arrowsmith
Chemical Linkers in Antibody–Drug Conjugates (ADCs)
Check Access
Floris van Delft; John M. Lambert
César Muñoz-Fontela; Rafael Delgado
Patrick Schnider
Protein – Protein Interaction Regulators
Check Access
Siddhartha Roy; Haian Fu
Phenotypic Drug Discovery
Check Access
Beverley Isherwood; Angelique Augustin
New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs
Check Access
Mauro Maccarrone
Artificial Intelligence in Drug Discovery
Check Access
Nathan Brown
Protein Degradation with New Chemical Modalities
Check Access
Hilmar Weinmann; Craig Crews
Anti-fibrotic Drug Discovery
Check Access
Jehrod Brenneman; Malliga R Iyer
Ved Srivastava
Cytotoxic Payloads for Antibody – Drug Conjugates
Check Access
David E Thurston; Paul J M Jackson
Emerging Drugs and Targets for Multiple Sclerosis
Check Access
Ana Martinez
Philip V Peplow; Bridget Martinez; George A Calin; Aurora Esquela-Kerscher
Advances in Nucleic Acid Therapeutics
Check Access
Sudhir Agrawal; Michael J Gait
Kinase Drug Discovery: Modern Approaches
Check Access
Richard A Ward; Frederick W Goldberg